[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.129.82. Please contact the publisher to request reinstatement.
Viewpoint
August 2016

Treatment of Regional Lymph Nodes in Breast Cancer—Not Recommended for All Patients With 1 to 3 Positive Auxiliary Nodes

Author Affiliations
  • 1Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
JAMA Oncol. 2016;2(8):991-992. doi:10.1001/jamaoncol.2016.0222

Should all women with positive nodes in breast cancer receive comprehensive nodal irradiation?—No.

I would say that some node-positive patients should get comprehensive nodal irradiation (RT), but I don’t believe the current data supports its use in all node-positive patients, particularly in patients with 1 to 3 positive nodes. Advocates for routine use of comprehensive nodal RT in node-positive patients point to 2 main sources: the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) meta-analysis of post-mastectomy RT (PMRT),1 and the MA.20 clinical trial.2

×